BeiGene, Ltd.
TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF
Last updated:
Abstract:
Disclosed herein is a tricyclic compound of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
17 Jul 2020
Issue date:
25 Aug 2022